Showing results (41-50 of 85) with videos related to

Sort By:
Pageof 9
Molecular Diversity|August 14, 2024
Multicomponent reaction for synthesis, molecular docking, and anti-inflammatory evaluation of novel indole-thiazole hybrid derivativesFaeza Alkorbi, Shareefa Ahmed Alshareef, Mahmoud A Abdelaziz, et al.
Infectious Agents and Cancer|January 28, 2025
The role of lipids and lipids lowering drugs in human papillomavirus (HPV) and HPV-associated cancersEhsan Shabani, Aida Hasanzadi, Omer Qutaiba B Allela, et al.
ACS Omega|July 11, 2022
Efficient and Recoverable Bio-Organic Catalyst Cysteine for Synthesis, Docking Study, and Antifungal Activity of New Bio-Active 3,4-Dihydropyrimidin-2(1H)-ones/thiones Under Microwave IrradiationNadia A A Elkanzi, Asmaa M Kadry, Rasha M Ryad, et al.
BMC Pregnancy and Childbirth|June 5, 2016
The status of maternal and newborn health care services in ZanzibarBakar Fakih, Azzah A S Nofly, Ali O Ali, et al.
Pathology, Research and Practice|September 5, 2024
Circular RNAs as a novel molecular mechanism in diagnosis, prognosis, therapeutic target, and inhibiting chemoresistance in breast cancerNafiseh Tashakori, Maria V Mikhailova, Zainab Abbas Mohammedali, et al.
Applied Biochemistry and Biotechnology|January 4, 2026
An Overview of the Effects of Exercise on Viral Infection in Obesity: Recent Advances and Potential MechanismsAli Eslami, Arman Ghayourvahdat, Faris Anad Muhammad, et al.
Molecules (Basel, Switzerland)|September 23, 2022
Pumice as a Novel Natural Heterogeneous Catalyst for the Designation of 3,4-Dihydropyrimidine-2-(1H)-ones/thiones under Solvent-Free ConditionsHany M Abd El-Lateef, Mohamed Gouda, Mai M Khalaf, et al.
Biochemical Genetics|August 5, 2024
MicroRNA as Key Players in Hepatocellular Carcinoma: Insights into Their Role in MetastasisMohamed J Saadh, Qusay Mohammed Hussain, Tuqa S Alazzawi, et al.
Neuromolecular Medicine|September 5, 2025
Engineering the Microbiome: a Novel Approach to Managing Autoimmune DiseasesThabit Moath Omar, Karar H Alfarttoosi, Gaurav Sanghvi, et al.
RSC Advances|September 9, 2024
Design and evaluation of sulfadiazine derivatives as potent dual inhibitors of EGFRWT and EGFRT790M: integrating biological, molecular docking, and ADMET analysisHany M Abd El-Lateef, Hend A A Ezelarab, Ali M Ali, et al.
Pageof 9